Pharmagest Interactive
Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare p… Read more
Pharmagest Interactive (0R9T) - Total Liabilities
Latest total liabilities as of June 2025: €171.66 Million EUR
Based on the latest financial reports, Pharmagest Interactive (0R9T) has total liabilities worth €171.66 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pharmagest Interactive - Total Liabilities Trend (2004–2024)
This chart illustrates how Pharmagest Interactive's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Pharmagest Interactive Competitors by Total Liabilities
The table below lists competitors of Pharmagest Interactive ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jahen Household Products Co. Ltd.
SHE:300955
|
China | CN¥1.04 Billion |
|
Mi Technovation Berhad
PINK:MITNF
|
USA | $37.73 Million |
|
Misun Technology Co Ltd
SHE:301577
|
China | CN¥326.73 Million |
|
Alector Inc
NASDAQ:ALEC
|
USA | $262.59 Million |
|
Hemisphere Properties India Limited
NSE:HEMIPROP
|
India | ₹7.32 Billion |
|
Avacta Group Plc
PINK:AVCTF
|
USA | $29.09 Million |
|
FastPartner AB (publ)
ST:FPAR-A
|
Sweden | Skr21.51 Billion |
|
Xinjiang Xinxin Mining Industry Co. Ltd
F:33X1
|
Germany | €3.68 Billion |
Liability Composition Analysis (2004–2024)
This chart breaks down Pharmagest Interactive's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmagest Interactive's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmagest Interactive (2004–2024)
The table below shows the annual total liabilities of Pharmagest Interactive from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €157.32 Million | -5.46% |
| 2023-12-31 | €166.42 Million | +8.05% |
| 2022-12-31 | €154.01 Million | -6.50% |
| 2021-12-31 | €164.72 Million | +12.19% |
| 2020-12-31 | €146.82 Million | +16.35% |
| 2019-12-31 | €126.19 Million | +18.20% |
| 2018-12-31 | €106.76 Million | +45.77% |
| 2017-12-31 | €73.24 Million | +55.68% |
| 2016-12-31 | €47.05 Million | +45.09% |
| 2015-12-31 | €32.42 Million | +1.78% |
| 2014-12-31 | €31.86 Million | -4.43% |
| 2013-12-31 | €33.34 Million | -4.71% |
| 2012-12-31 | €34.98 Million | +8.12% |
| 2011-12-31 | €32.36 Million | -4.53% |
| 2010-12-31 | €33.89 Million | -5.83% |
| 2009-12-31 | €35.99 Million | -9.90% |
| 2008-12-31 | €39.95 Million | +10.24% |
| 2007-12-31 | €36.23 Million | -2.47% |
| 2006-12-31 | €37.15 Million | +34.48% |
| 2005-12-31 | €27.63 Million | +5.20% |
| 2004-12-31 | €26.26 Million | -- |